Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Adjuvant Chloroquine to the Conventional Treatment for Glioblastoma.

NCT04772846 is registered in ClinicalTrials.gov with Egyptian Medical Syndicate as lead sponsor.

NCT NCT04772846
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04772846 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Adjuvant Chloroquine to the Conventional Treatment for Glioblastoma.
Lead sponsor
Egyptian Medical Syndicate
Phase
Phase 1/2
Overall status
Unknown status
Start date
March 1, 2018
Completion date
March 31, 2021
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glioblastoma